Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol

Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome (PMS). Pharmacologic options studied for treating severe PMS and PMDD may include selective serotonin reuptake inhibitors, anxiolytic agents, gonadotropin-releasing hormone agonists and the diuretic spironolactone. Howe...

Full description

Saved in:
Bibliographic Details
Main Authors: De Berardis, Domenico, Serroni, Nicola, Salerno, Rosa Maria, Ferro, Filippo Maria
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2007
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2374943/
https://ncbi.nlm.nih.gov/pubmed/18472980
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items